COVID-19
| 2 min read
Researchers are conducting the first long-term prospective study to understand the immune response to COVID-19 long after initial infection.
| 4 min read
Investigating antibodies produced by infectious diseases yields vaccines with broad-acting protection.
| 3 min read
Researchers combined genome, phenotype, and proteome-wide association assays to identify protein variants associated with severe COVID-19, providing clues for how these proteins may contribute to disease.
| 2 min read
The moon landing inspired a generation of scientists. Could the COVID-19 pandemic inspire the next generation?
| 6 min read
Researchers plan to monitor the immune responses of COVID-19 patients for one year to see how they correlate with illness severity and lasting effects. This data will help develop personalized treatments for patients.
Available on Demand
LIVE June 22nd, 2021 at 2:30 PM ET
This webinar will explore recent discoveries about the way the immune system responds to SARS-CoV-2 infection.
| 9 min read
What happens after the vaccine is injected into your arm?
| 1 min read
Infectious diseases alter the traditional vaccine pipeline and spawn new approaches to antibody research and vaccine development.
| 5 min read
Erica Ollman Saphire brings together scientific competitors to find new antibody therapeutics for COVID-19.
| 2 min read
“Beyond COVID-19, we believe SMAs have huge potential to unblock constrictions in the drug pipeline.”
